Clinical Trial Update: Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults [Phase 2]

View source ↗

Summary

A Phase 2 field trial of Sanaria's PfSPZ-LARC2 malaria vaccine in Burkinabe adults is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ-LARC2

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria (Plasmodium Falciparum) | Phase 2 | Status: NOT_YET_RECRUITING